Teva seeks 'game-changing' M&A; India's Sun Pharma wants Japanese partners; Novo sees big growth in Pakistan;

@FiercePharma: Study: Pro-vaccine messages can intensify immunization opposition - FierceVaccines. More | Follow @FiercePharma

@TracyStaton: Which city boasts the most biotech VC funding? Check out the top 15 list at FierceBiotech. Report | Follow @TracyStaton

@EricPFierce: Baxter says it discovered mold in a dialysis product. FDA sent it a warning letter last year related to mold. Story | Follow @EricPFierce

@CarlyHFierce: "The constant threat of compulsory licences hangs like a Damocles sword over patent-holders." Article | Follow @CarlyHFierce

> Teva Pharmaceutical Industries ($TEVA) CFO Eyal Desheh says the Israeli drugmaker has "an appetite for game-changing deals." Report

> India's Sun Pharmaceutical Industries is looking for partnerships or deals as an entry into Japan, which is working to step up its use of generic drugs. Report

> Novo Nordisk ($NVO) is expecting 30% growth this year in Pakistan as the country sees a disturbing rise in the number of diabetes cases. Report

> A federal appeals court affirmed a summary judgment for Novartis ($NVS) in a liability lawsuit over alleged Zometa-related jaw injury. Report

> The French drugmaker Stallergenes said it hired a former Actelion ($ATLN) manager, Christian Chavy, to take over as its new chief executive. Report

> Cancer patients in England are up to seven times more likely to be treated with expensive drugs than are patients in Wales, a study found. Report

Medical Device News

@FierceMedDev: The vaginal mesh saga continues: Coloplast reportedly paid $16M to settle suits, sparking talk of a global settlement. More | Follow @FierceMedDev

@MarkHFierce: Navidea is trying to move its Lymphoseek cancer imaging agent forward in the mkt, and this $30M loan will help. Story | Follow @MarkHFierce

@GalenMoore: Upheld: Former Spectranetics CEO's conviction for lying to the feds over device smuggling allegations. Story | Follow @GalenMoore

@EmilyWFierce: Pulse Therapeutics' magnet-based technology could help deliver drugs to stroke patients faster, improving outcomes. News | Follow @EmilyWFierce

> Researchers find silk could replace metal in surgical devices. More

> Study gives KCI's wound therapy device a marketplace boost. Article

Biotech News

@FierceBiotech: Read about the reasons that put these 15 cities at the top of U.S. Report | Follow @FierceBiotech

@JohnCFierce: Forest's CNS partner Adamas shoots for #IPO gold in $69M offering. Story | Follow @JohnCFierce

@DamianFierce: Endo wins FDA nod for a "low-T" drug just as safety controversy reaches fever pitch. News | Follow @DamianFierce

@EmilyMFierce: Super cool: A new kind of wristband could measure individual exposure to environmental toxins. More | Follow @EmilyMFierce

> Obama administration looks to chop back market exclusivity for biologics. Story

> ZS Pharma bags $55M to take its kidney drug to the FDA. More

Pharma Manufacturing News

> Baxter recalls a dialysis product due to mold. News

> Plant issues cost Lilly, Boehringer Ingelheim a drug approval. Story

> Lilly and its partner Novast start work on a plant in China. Story

> Sagent recalls drug because of leaking bags. News

> Bloomberg: Worker safety also an issue with Ranbaxy plant. Article

> GSK shares grant to help U.K. on how to rebuild its drug manufacturing base. Brief

Vaccines News

> U.K. facing $100M compensation payout relating to GSK's swine flu vaccine. Report

> Study: Merck's Gardasil halves risk of precancerous lesions. Story

> Sanofi makes inactive polio vax available to poor countries for a buck a dose. Article

> CDC reports switch to 2-dose regimen of Merck's chickenpox vaccine a success. Story

> Pro-vaccine messages can intensify immunization opposition. Study

> Antibody discovery opens new avenue for HIV vaccine development. Brief

And Finally... Nearly half a million American probably died from Alzheimer's disease in 2010, a number almost six times previous estimates. Report

Suggested Articles

Transporting pharmaceutical products at <-60C for more than 96 hours has seemed an insurmountable challenge. TOWER’s solution has solved the problem.

The countdown to the FDA's first coronavirus vaccine hearing has begun, and new agency documents outline an agenda for the Thursday confab.

Black Americans’ confidence in COVID-19 vaccines is dropping, with only 43% saying they will get a vaccine once it's out—down 22 points since August.